The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection
Open accessAbstract
BACKGROUND: While inflammation predicts mortality in treated human immunodeficiency virus (HIV) infection, the prognostic significance of gut barrier dysfunction and phenotypic T-cell markers remains unclear. METHODS: We assessed immunologic predictors of mortality in a case-control study within the Longitudinal Study of the Ocular Complications of AIDS (LSOCA), using conditional logistic regression. Sixty-four case patients who died within 12 months of treatment-mediated viral suppression were each matched to 2 control individuals (total number of controls, 128) by duration of antiretroviral therapy-mediated viral suppression, nadir CD4(+) T-cell count, age, sex, and prior cytomegalovirus (CMV) retinitis. A similar secondary analysis was conducted in the SCOPE cohort, which had participants with less advanced immunodeficiency. RESULTS: Plasma gut epithelial barrier integrity markers (intestinal fatty acid binding protein and zonulin-1 levels), soluble CD14 level, kynurenine/tryptophan ratio, soluble tumor necrosis factor receptor 1 level, high-sensitivity C-reactive protein level, and D-dimer level all strongly predicted mortality, even after adjustment for proximal CD4(+) T-cell count (all P ≤ .001). A higher percentage of CD38(+)HLA-DR(+) cells in the CD8(+) T-cell population was a predictor of mortality before (P = .031) but not after (P = .10) adjustment for proximal CD4(+) T-cell count. Frequencies of senescent (defined as CD28(-)CD57(+) cells), exhausted (defined as PD1(+) cells), naive, and CMV-specific T cells did not predict mortality. CONCLUSIONS: Gut epithelial barrier dysfunction, innate immune activation, inflammation, and coagulation-but not T-cell activation, senescence, and exhaustion-independently predict mortality in individuals with treated HIV infection with a history of AIDS and are viable targets for interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Self-citation(2008) · The Lancet · doi:10.1016/s0140-6736(08)61113-7 · Cited by 1,661 · cited 1×
“Despite antiretroviral therapy (ART), human immunodeficiency virus type 1 (HIV-1)–infected individuals have a shorter life expectancy and greater morbidity than the general population, particularly when ART is delayed until disease is advanced [1–4].”
Background. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
. Plasma levels of soluble CD14 independently predict mortality in HIV infection.
Sandler, N. G., Wand, H., Roque, A., Law, M., Nason, M. C., Nixon, D. E., Pedersen, C., Ruxrungtham, K., Lewin, S. R., Emery, S., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq118 · Cited by 1,106 · cited 2×
“sCD14 levels predicted mortality in the SMART trial, I-FABP levels did not [18].”
BackgroundSelf-citationGiorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B., Jacobson, L. P., Shih, R., Lewis, J., Wiley, D. J., Phair, J. P., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314660 · Cited by 1,033
Fasano, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2008 · Cited by 1,003
Hunt, P. W., Martin, J. N., Sinclair, E., Bredt, B., Hagos, E., Lampiris, H., & Deeks, S. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374786 · Cited by 852
Self-citation. Survival of persons with and without HIV infection in Denmark, 1995-2005.
Lohse, N., Hansen, A.-B. E., Pedersen, G., Kronborg, G., Gerstoft, J., Sørensen, H. T., Væth, M., & Obel, N. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00003 · Cited by 748
Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism
Vujkovic-Cvijin, I., Dunham, R. M., Iwai, S., Maher, M. C., Albright, R. G., Broadhurst, M. J., Hernandez, R. D., Lederman, M. M., Huang, Y., Somsouk, M., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006438 · Cited by 738
Self-citationFavre, D., Mold, J., Hunt, P. W., Kanwar, B., Loke, P., Seu, L., Barbour, J. D., Lowe, M. M., Jayawardene, A., Aweeka, F., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000632 · Cited by 523
Self-citationHadrup, S. R., Strindhall, J., Køllgaard, T., Seremet, T., Johansson, B., Pawelec, G., thor Straten, P., & Wikby, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2645 · Cited by 471
Wikby, A. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00212-1 · Cited by 414
van Sighem, A., Gras, L., Reiss, P., Brinkman, K., & de Wolf, F. (2010) · AIDS · doi:10.1097/qad.0b013e32833a3946 · Cited by 398
Almanzar, G., Schwaiger, S., Jenewein, B., Keller, M., Herndler-Brandstetter, D., Würzner, R., Schönitzer, D., & Grubeck-Loebenstein, B. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3675-3683.2005 · Cited by 357
Hunt, P. W., Martin, J. N., Sinclair, E., Epling, L., Teague, J., Jacobson, M. A., Tracy, R. P., Corey, L., & Deeks, S. G. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir060 · Cited by 344
Self-citationAssociation of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction
Triant, V. A., Meigs, J. B., & Grinspoon, S. K. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181a9992c · Cited by 338
Burdo, T. H., Lentz, M. R., Autissier, P., Krishnan, A., Halpern, E., Letendre, S., Rosenberg, E. S., Ellis, R. J., & Williams, K. C. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir214 · Cited by 336
Jain, V., Hartogensis, W., Bacchetti, P., Hunt, P. W., Hatano, H., Sinclair, E., Epling, L., Lee, T.-H., Busch, M. P., McCune, J. M., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit311 · Cited by 320
Self-citationBoulware, D. R., Hullsiek, K. H., Puronen, C. E., Rupert, A., Baker, J. V., French, M. A., Bohjanen, P. R., Novak, R. M., Neaton, J. D., & Sereti, I. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir134 · Cited by 314
Boasso, A., Herbeuval, J.-P., Hardy, A. W., Anderson, S. A., Dolan, M. J., Fuchs, D., & Shearer, G. M. (2007) · Blood · doi:10.1182/blood-2006-07-034785 · Cited by 288
. Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.
Tien, P. C., Choi, A. I., Zolopa, A. R., Benson, C., Tracy, R., Scherzer, R., Bacchetti, P., Shlipak, M., & Grunfeld, C. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181e66216 · Cited by 279 · cited 2×
“flammatory and coagulation markers remain abnormally high despite suppressive ART and predict this increased morbidity and mortality [5–17].”
BackgroundBurdo, T. H., Weiffenbach, A., Woods, S. P., Letendre, S., Ellis, R. J., & Williams, K. C. (2013) · AIDS · doi:10.1097/qad.0b013e32836010bd · Cited by 263
The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, Lewden, C., Bouteloup, V., De Wit, S., Sabin, C., Mocroft, A., Wasmuth, J. C., van Sighem, A., Kirk, O., Obel, N., et al. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr164 · Cited by 252
Hatano, H., Jain, V., Hunt, P. W., Lee, T.-H., Sinclair, E., Do, T. D., Hoh, R., Martin, J. N., McCune, J. M., Hecht, F., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis630 · Cited by 251
Self-citationGiorgi, J. V., Lyles, R. H., Matud, J. L., Yamashita, T. E., Mellors, J. W., Hultin, L. E., Jamieson, B. D., Margolick, J. B., Rinaldo, C. R., Phair, J. P., et al. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200204010-00004 · Cited by 246
Brown, T. T., Tassiopoulos, K., Bosch, R. J., Shikuma, C., & McComsey, G. A. (2010) · Diabetes Care · doi:10.2337/dc10-0633 · Cited by 236
Hunt, P. W., Cao, H. L., Muzoora, C., Ssewanyana, I., Bennett, J., Emenyonu, N., Kembabazi, A., Neilands, T. B., Bangsberg, D. R., Deeks, S. G., et al. (2011) · AIDS · doi:10.1097/qad.0b013e32834c4ac1 · Cited by 224
Self-citationLyons, J. L., Uno, H., Ancuta, P., Kamat, A., Moore, D. J., Singer, E. J., Morgello, S., & Gabuzda, D. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182237e54 · Cited by 213
Justice, A. C., Freiberg, M. S., Tracy, R., Kuller, L., Tate, J. P., Goetz, M. B., Fiellin, D. A., Vanasse, G. J., Butt, A. A., Rodriguez-Barradas, M. C., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir989 · Cited by 203
Self-citationFord, E. S., Greenwald, J. H., Richterman, A. G., Rupert, A., Dutcher, L., Badralmaa, Y., Natarajan, V., Rehm, C., Hadigan, C., & Sereti, I. (2010) · AIDS · doi:10.1097/qad.0b013e32833ad914 · Cited by 195
Gandhi, R. T., Spritzler, J., Chan, E., Asmuth, D. M., Rodriguez, B., Merigan, T. C., Hirsch, M. S., Shafer, R. W., Robbins, G. K., & Pollard, R. B. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000226789.51992.3f · Cited by 165
Self-citationHunt, P. W., Shulman, N. S., Hayes, T. L., Dahl, V., Somsouk, M., Funderburg, N., McLaughlin, B. E., LANDAY, A. L., Adeyemi, O. M., Gilman, L. T., et al. (2013) · Blood · doi:10.1182/blood-2012-06-436345 · Cited by 150
Self-citationByakwaga, H., Boum, Y., Huang, Y., Muzoora, C. K., Kembabazi, A., Weiser, S. D., Bennett, J., Cao, H., Haberer, J. E., Deeks, S. G., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu115 · Cited by 138
Self-citationKalayjian, R. C., Machekano, R. N., Rizk, N., Robbins, G. K., Gandhi, R. T., Rodriguez, B. A., Pollard, R. B., Lederman, M. M., & LANDAY, A. L. (2010) · The Journal of Infectious Diseases · doi:10.1086/652750 · Cited by 137
Self-citationGoicoechea, M., Smith, D. M., Liu, L., May, S. J., Tenorio, A. R., Ignacio, C. C., LANDAY, A. L., & Haubrich, R. (2006) · The Journal of Infectious Diseases · doi:10.1086/504718 · Cited by 114
Lipoprotein particle subclasses, cardiovascular disease and HIV infection
Duprez, D. A., Kuller, L. H., Tracy, R. P., Otvos, J. D., Cooper, D. A., Hoy, J., Neuhaus, J., Paton, N. I., Friis‐Møller, N., Lampe, F. C., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.05.001 · Cited by 111
Ledwaba, L., Tavel, J. A., Khabo, P., Maja, P., Qin, J., Sangweni, P., Liu, X., Follmann, D. A., Metcalf, J. A., Orsega, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0024243 · Cited by 104
Vescovini, R., Biasini, C., Telera, A. R., Basaglia, M., Stella, A., Magalini, F., Bucci, L., Monti, D., Lazzarotto, T., Monte, P. D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902890 · Cited by 91
Huang, Y., Louie, A., Yang, Q., Massenkoff, N., Xu, C., Hunt, P. W., & Gee, W. L. (2013) · Bioanalysis · doi:10.4155/bio.13.74 · Cited by 79
Self-citationLee, S. A., Sinclair, E., Jain, V., Huang, Y., Epling, L., Natta, M. L. V., Meinert, C. L., Martin, J. N., McCune, J. M., Deeks, S. G., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu109 · Cited by 57
Self-citationThe Effect of Leflunomide on Cycling and Activation of T-Cells in HIV-1-Infected Participants
Read, S. W., DeGrezia, M. G., Ciccone, E. J., DerSimonian, R., Higgins, J. M., Adelsberger, J. W., Starling, J. M., Rehm, C. A., & Sereti, I. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011937 · Cited by 45
Hatano, H., Scherzer, R., Wu, Y., Harvill, K., Maka, K., Hoh, R., Sinclair, E., Palmer, S., Martin, J. N., Busch, M. P., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31826e7d0f · Cited by 40
Self-citationLok, J. J., Hunt, P. W., Collier, A. C., Benson, C. A., Witt, M. D., Luque, A. E., Deeks, S. G., & Bosch, R. J. (2013) · AIDS · doi:10.1097/qad.0b013e32836191b1 · Cited by 17
Self-citation
Cited by
Deeks, S. G., Overbaugh, J., Phillips, A., & Buchbinder, S. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.35 · Cited by 644
Self-citationThe ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
Griesenauer, B., & Paczesny, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00475 · Cited by 619
Sturgeon, C., & Fasano, A. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1251384 · Cited by 497
Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression
Sandler, N. G., Bosinger, S. E., Estes, J. D., Zhu, R. T. R., Tharp, G. K., Boritz, E., Levin, D., Wijeyesinghe, S., Makamdop, K. N., del Prete, G. Q., et al. (2014) · Nature · doi:10.1038/nature13554 · Cited by 461
Peluso, M. J., Lu, S., Tang, A. F., Durstenfeld, M. S., Ho, H.-E., Goldberg, S. A., Forman, C. A., Munter, S. E., Hoh, R., Tai, V., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab490 · Cited by 320
Self-citation
Metadata
- Authors
- Hunt, P. W., Sinclair, E., Rodriguez, B., Shive, C., Clagett, B., Funderburg, N., Robinson, J., Huang, Y., Epling, L., Martin, J. N., Deeks, S. G., Meinert, C. L., Van Natta, M. L., Jabs, D. A., & Lederman, M. M.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-04-21
- Volume
- 210
- Issue
- 8
- Pages
- 1228-1238
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2098836196
- Cited by
- 478
- References
- 43
- FWCI
- 21.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.